Literature DB >> 22564442

Presynaptic mGlu7 receptors control GABA release in mouse hippocampus.

Maria Summa1, Silvia Di Prisco, Massimo Grilli, Cesare Usai, Mario Marchi, Anna Pittaluga.   

Abstract

The functional role of presynaptic release-regulating metabotropic glutamate type 7 (mGlu7) receptors in hippocampal GABAergic terminals was investigated. Mouse hippocampal synaptosomes were preloaded with [(3)H]D-γ-aminobutyric acid ([(3)H]GABA) and then exposed in superfusion to 12 mM KCl. The K(+)-evoked [(3)H]GABA release was inhibited by the mGlu7 allosteric agonist N,N'-dibenzyhydryl-ethane-1,2-diamine dihydrochloride (AMN082, 0.001-10 μM), as well as by the group III mGlu receptor agonist l-(+)-2-amino-4-phosphonobutyric acid [(l)-AP4, 0.01-1 mM]. The mGlu8 receptor agonist (S)-3,4-dicarboxyphenylglycine [(S)-3,4-DCPG, 10-100 nM] was ineffective. AMN082 and (l)-AP4-induced effects were recovered by the mGlu7 negative allosteric modulator (NAM) 6-(4-methoxyphenyl)-5-methyl-3-(4-pyridinyl)-isoxazolo[4,5-c]pyridin-4(5H)-one hydrochloride (MMPIP). AMN082 also inhibited in a MMPIP-sensitive manner the K(+)-evoked release of endogenous GABA. AMN082 and the adenylyl cyclase (AC) inhibitor MDL-12,330A reduced [(3)H]GABA exocytosis in a 8-Br-cAMP-sensitive. AMN082-inhibitory effect was additive to that caused by (-)baclofen, but insensitive to the GABA(B) antagonist 3-[[(3,4-Dichlorophenyl)methyl]amino]propyl] diethoxymethyl) phosphinic acid (CGP52432). Conversely, (-)baclofen-induced inhibition of GABA exocytosis was insensitive to MMPIP. Finally, the forskolin-evoked [(3)H]GABA release was reduced by AMN082 or (-)baclofen but abolished when the two agonists were added concomitantly. Mouse hippocampal synaptosomal plasmamembranes posses mGlu7 receptor proteins; confocal microscopy analysis unveiled that mGlu7 proteins colocalize with syntaxin-1A (Stx-1A), with vesicular GABA transporter (VGAT)-proteins and with GABA(B) receptor subunit proteins. We propose that presynaptic inhibitory mGlu7 heteroreceptors, negatively coupled to AC-dependent intraterminal pathway, exist in mouse hippocampal GABA-containing terminals, where they colocalize, but do not functionally cross-talk, with GABA(B) autoreceptors. This article is part of a Special Issue entitled 'Metabotropic Glutamate Receptors'.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22564442     DOI: 10.1016/j.neuropharm.2012.04.020

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  22 in total

1.  Activation of Metabotropic Glutamate Receptor 7 Is Required for Induction of Long-Term Potentiation at SC-CA1 Synapses in the Hippocampus.

Authors:  Rebecca Klar; Adam G Walker; Dipanwita Ghose; Brad A Grueter; Darren W Engers; Corey R Hopkins; Craig W Lindsley; Zixiu Xiang; P Jeffrey Conn; Colleen M Niswender
Journal:  J Neurosci       Date:  2015-05-13       Impact factor: 6.167

2.  Elfn1-Induced Constitutive Activation of mGluR7 Determines Frequency-Dependent Recruitment of Somatostatin Interneurons.

Authors:  Tevye Jason Stachniak; Emily Lauren Sylwestrak; Peter Scheiffele; Benjamin J Hall; Anirvan Ghosh
Journal:  J Neurosci       Date:  2019-04-02       Impact factor: 6.167

3.  Immuno-Pharmacological Characterization of Presynaptic GluN3A-Containing NMDA Autoreceptors: Relevance to Anti-NMDA Receptor Autoimmune Diseases.

Authors:  Guendalina Olivero; Matteo Vergassola; Francesca Cisani; Cesare Usai; Anna Pittaluga
Journal:  Mol Neurobiol       Date:  2019-02-07       Impact factor: 5.590

4.  Metabotropic Glutamate Receptor Subtype 7 in the Bed Nucleus of the Stria Terminalis is Essential for Intermale Aggression.

Authors:  Miwako Masugi-Tokita; Peter J Flor; Mitsuhiro Kawata
Journal:  Neuropsychopharmacology       Date:  2015-07-07       Impact factor: 7.853

5.  Acute desipramine restores presynaptic cortical defects in murine experimental autoimmune encephalomyelitis by suppressing central CCL5 overproduction.

Authors:  Silvia Di Prisco; Elisa Merega; Massimiliano Lanfranco; Simona Casazza; Antonio Uccelli; Anna Pittaluga
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

6.  Phenotypic profiling of mGlu7 knockout mice reveals new implications for neurodevelopmental disorders.

Authors:  Nicole M Fisher; Robert W Gould; Rocco G Gogliotti; Annalise J McDonald; Hana Badivuku; Susmita Chennareddy; Aditi B Buch; Annah M Moore; Matthew T Jenkins; W Hudson Robb; Craig W Lindsley; Carrie K Jones; P Jeffrey Conn; Colleen M Niswender
Journal:  Genes Brain Behav       Date:  2020-04-14       Impact factor: 3.449

7.  Presynaptic, release-regulating mGlu2 -preferring and mGlu3 -preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease.

Authors:  Silvia Di Prisco; Elisa Merega; Tommaso Bonfiglio; Guendalina Olivero; Chiara Cervetto; Massimo Grilli; Cesare Usai; Mario Marchi; Anna Pittaluga
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

8.  CXCR4 and NMDA Receptors Are Functionally Coupled in Rat Hippocampal Noradrenergic and Glutamatergic Nerve Endings.

Authors:  Silvia Di Prisco; Guendalina Olivero; Elisa Merega; Tommaso Bonfiglio; Mario Marchi; Anna Pittaluga
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-05       Impact factor: 4.147

9.  Immuno-pharmacological characterization of group II metabotropic glutamate receptors controlling glutamate exocytosis in mouse cortex and spinal cord.

Authors:  Guendalina Olivero; Tommaso Bonfiglio; Matteo Vergassola; Cesare Usai; Barbara Riozzi; Giuseppe Battaglia; Ferdinando Nicoletti; Anna Pittaluga
Journal:  Br J Pharmacol       Date:  2017-10-29       Impact factor: 8.739

10.  Antibodies Against the NH2-Terminus of the GluA Subunits Affect the AMPA-Evoked Releasing Activity: The Role of Complement.

Authors:  Francesca Cisani; Guendalina Olivero; Cesare Usai; Gilles Van Camp; Stefania Maccari; Sara Morley-Fletcher; Anna Maria Pittaluga
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.